April 11, 2014
Chugai Pharmaceutical announced on April 9 that it filed on the same day a new drug application (NDA) with the Ministry of Health, Labor and welfare (MHLW) for its malignant melanoma treatment vemurafenib (development code: RG7204) for the treatment of...read more